Saccharomyces Cerevisiae
GET
/api/v1/drug/saccharomyces-cerevisiaeIndications
Sourced from openFDA- Allergies.
Dosage & administration
Sourced from openFDASUGGESTED DOSAGE Normal dose for the first week is 2-3 drops in water T.I.D. Add one drop per dose per week until a total of ten drops is reached.
Warnings & precautions
Sourced from openFDAUse only if cap seal is unbroken. If pregnant or breastfeeding, ask a healthcare professional before use. Keep this and all medication out of the reach of children.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
793 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Diarrhoea10113%
- 2Fatigue749.3%
- 3Nausea708.8%
- 4Fall587.3%
- 5Headache546.8%
- 6Pneumonia536.7%
- 7Off Label Use475.9%
- 8Urinary Tract Infection445.5%
- 9Pain435.4%
- 10Vomiting415.2%
- 11Weight Decreased415.2%
- 12Dyspnoea405.0%
- 13Pyrexia405.0%
- 14Covid-19384.8%
- 15Arthralgia374.7%
Literature
Recent PubMed references pinned to Saccharomyces Cerevisiae as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Boosting the Valorization of Pigmented Corn Cobs Through Solid-State Fermentation with Saccharomyces cerevisiae.Molecules (Basel, Switzerland) · 2026 · Agustín-Chávez MC, Ramírez-Esparza U, Ochoa-Reyes E, et al.PMID 42280197DOI 10.3390/molecules31111895
- Observing intersubunit dynamics in single yeast ribosomes.Nucleic acids research · 2026 · Das A, Grove AK, Ivanov AV, et al.PMID 42261778DOI 10.1093/nar/gkag576
- Systems-Level Metabolic Regulation Strategies of Xylose Metabolism in Saccharomyces cerevisiae.Biotechnology journal · 2026 · Gao S, Liu ZH, Zhang HR, et al.PMID 42261631DOI 10.1002/biot.70258
- Uncoupling the TFIIH Core and Kinase Modules leads to misregulated RNA polymerase II CTD Serine 5 phosphorylation.eLife · 2026 · Giordano G, Buratowski R, Jeronimo C, et al.PMID 42258375DOI 10.7554/eLife.110091
- Engineering peroxisomal cofactor systems in Saccharomyces cerevisiae for enhanced biosynthesis of α-humulene.World journal of microbiology & biotechnology · 2026 · Li Y, Tian Y, Ma Y, et al.PMID 42257761DOI 10.1007/s11274-026-05060-3
- Terephthalate, a plastic monomer, triggers phosphate metabolism rewiring in yeast.Proceedings of the National Academy of Sciences of the United States of America · 2026 · Takallou S, Lancaster R, Kinshin S, et al.PMID 42228540DOI 10.1073/pnas.2537088123
- Glucose starvation signaling via nucleus-vacuole junction remodeling controls ergosterol synthesis.The Journal of cell biology · 2026 · Fujimoto S, Tamura YPMID 42227952DOI 10.1083/jcb.202506071
- Modified and activated clinoptilolites ameliorate the cadmium and lead-induced genotoxicity in eukaryotic cells.Environmental geochemistry and health · 2026 · Todorova T, Boyadzhiev K, Kulekova S, et al.PMID 42223729DOI 10.1007/s10653-026-03274-w
Clinical trials
The 10 most recently updated of 101 ClinicalTrials.gov registrations naming Saccharomyces Cerevisiae as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Effect of Probiotics on Relapsing-Remitting Multiple SclerosisCompleted · Interventional · 60 enrolled · Cairo UniversityNCT07346924updated 2026-06-08
- A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial OvergrowthCompleted · Interventional · 9 enrolled · National University of Natural MedicineNCT07215676updated 2026-05-12
- The Effect of Rhythmic Auditory Stimulation on VOR Gain Adaptation Among Healthy Adults - A Randomized Clinical Trial "VOR - Vestibulo-ocular Reflex"Completed · Interventional · 12 enrolled · University of HaifaNCT07347470updated 2026-05-01
- Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease.Completed · Phase 2 · Interventional · 35 enrolled · University Hospital, LilleNCT02997059updated 2026-04-21
- Improving Iron Levels in Female Endurance, Intermittent, and Power/Strength Athletes Aged 16-35Recruiting · Interventional · 36 enrolled · University of CalgaryNCT06942208updated 2026-04-17
- Yeast Mannans and Stool FrequencyActive not recruiting · Interventional · 70 enrolled · University of FloridaNCT06911177updated 2026-04-15
- Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer PatientsRecruiting · Interventional · 52 enrolled · Fondazione del Piemonte per l'OncologiaNCT07514754updated 2026-04-07
- Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese AdultsActive not recruiting · Interventional · 40 enrolled · FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & InnovationNCT07240246updated 2026-03-30
- Effect of Music on Cue Reactivity for Patients With Opioid Use DisorderCompleted · Interventional · 28 enrolled · Brigham and Women's HospitalNCT06948890updated 2026-03-04
- Biomarker Assessments of Leukine During Treatment of Parkinson's DiseaseCompleted · Phase 1 · Interventional · 7 enrolled · University of NebraskaNCT03790670updated 2025-12-10
Frequently asked questions
- What is Saccharomyces Cerevisiae used for?
- According to FDA labeling, Saccharomyces Cerevisiae carries indications including: Allergies.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Saccharomyces Cerevisiae?
- Saccharomyces Cerevisiae is classified as Non-Standardized Food Allergenic Extract, Non-Standardized Fungal Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release, Increased IgG Production.
Note. Data for
saccharomyces-cerevisiae is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.